Nootropic
Emoxypine
SaveA synthetic analog of pyridoxine (vitamin B6) developed in Russia and marketed as Mexidol. Studied as an antioxidant and anxiolytic with membrane-stabilizing properties.
Quick verdict
Approved in Russia for cerebrovascular conditions and anxiety. Western clinical data is limited, but the safety profile appears benign.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Russian clinical trials report neuroprotective and anxiolytic effects in cerebral ischemia and alcohol withdrawal. Mechanism involves free-radical scavenging and modulation of GABA-benzodiazepine receptors. Few studies in Western journals.
Benefits
- Antioxidant and membrane-stabilizing properties
- Reported anxiolytic effects in Russian clinical use
- May protect against ischemic neuronal damage
Dosage notes
Russian prescribing typically uses 125–250 mg two to three times daily (oral or injectable).
Side effects
- Nausea
- Drowsiness
- Allergic reactions (rare)
Who should be cautious
Not approved outside Russia and some CIS countries. Limited long-term safety data in Western literature.
What this page cannot tell you
Most evidence comes from Russian clinical practice. Independent Western replication is sparse.
Leaderboard scores
- Anxiety40
- Stress35
- Longevity25
Write a review
Sign in to write a review.